SPRO — SPERO THERAPEUTICS

Ownership history in NewEdge Advisors, LLC  ·  11 quarters on record

This page tracks every 13F SEC filing in which NewEdge Advisors, LLC reported a position in SPERO THERAPEUTICS (SPRO). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 UNCHANGED 100 — 0% 0.00% $188 $1.88
2025 Q2 UNCHANGED 100 — 0% 0.00% $290 $2.90
2025 Q1 UNCHANGED 100 — 0% 0.00% $72 $0.72
2024 Q4 UNCHANGED 100 — 0% 0.00% $103 $1.03
7 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    SPRO price (monthly, adj. close)

Other funds also holding SPRO

As of 2025 Q4 — sorted by position size

GSK plc 2.68% PFIZER INC 2.33% INTREPID FAMILY OFFICE LLC 3Y 0.33% Anson Funds Management LP 3Y 7Y 0.14% Alphabet Inc. 3Y 0.08% Ionic Capital Management LLC 3Y 7Y 0.06% Informed Momentum Co LLC 3Y 7Y 0.06% GSA CAPITAL PARTNERS LLP 3Y 7Y 0.04% ADAR1 Capital Management, LLC 0.02% Shay Capital LLC 3Y 0.01%
← Back to NewEdge Advisors, LLC Holdings